Cargando…
Maternal cardiometabolic markers are associated with fetal growth: a secondary exploratory analysis of the LIMIT randomised trial
BACKGROUND: To determine the association between maternal cardiometabolic and inflammatory markers with measures of fetal biometry and adiposity. METHODS: Women included in this exploratory analysis were randomised to the ‘Standard Care’ group (N = 911) from the LIMIT randomised trial involving a to...
Autores principales: | O’Brien, Cecelia M., Louise, Jennie, Deussen, Andrea, Dodd, Jodie M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785858/ https://www.ncbi.nlm.nih.gov/pubmed/31601214 http://dx.doi.org/10.1186/s12902-019-0416-x |
Ejemplares similares
-
In Overweight or Obese Pregnant Women, Maternal Dietary Factors are not Associated with Fetal Growth and Adiposity
por: O’Brien, Cecelia M., et al.
Publicado: (2018) -
A Randomised Trial to Optimise Gestational Weight Gain and Improve Maternal and Infant Health Outcomes through Antenatal Dietary, Lifestyle and Exercise Advice: The OPTIMISE Randomised Trial
por: Dodd, Jodie M., et al.
Publicado: (2019) -
Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial
por: Poprzeczny, Amanda J., et al.
Publicado: (2020) -
The effect of an antenatal lifestyle intervention in overweight and obese women on circulating cardiometabolic and inflammatory biomarkers: secondary analyses from the LIMIT randomised trial
por: Moran, Lisa J., et al.
Publicado: (2017) -
Optimising gestational weight gain and improving maternal and infant health outcomes through antenatal dietary, lifestyle and physical activity advice: the OPTIMISE randomised controlled trial protocol
por: Dodd, Jodie M, et al.
Publicado: (2018)